MN-001 BID ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
226Interstitial cystitis with Hunners ulcer1

226. Interstitial cystitis with Hunners ulcer


Clinical trials : 143 Drugs : 171 - (DrugBank : 56) / Drug target genes : 64 - Drug target pathways : 145
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00295854
(ClinicalTrials.gov)
May 200522/2/2006Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial CystitisA Phase II, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial CystitisInterstitial CystitisDrug: MN-001 BID;Drug: MN-001;Drug: PlaceboMediciNovaNULLCompleted18 YearsN/AAll296Phase 2United States